Comparison of activity ability and indicators of brain injury
| Study group (n=65) | Control group (n=65) | t | P value | |
| Mean activity score | ||||
| Before treatment | 43.59±4.29 | 44.83±4.02 | −1.7 | 0.092 |
| After treatment | 73.29±6.39 | 66.94±5.98 | 5.85 | <0.001* |
| Mean NSE, µg/L | ||||
| Before treatment | 41.98±6.93 | 42.12±7.01 | −0.115 | 0.909 |
| After treatment | 11.02±4.08 | 19.38±3.87 | −11.986 | <0.001* |
| Mean S100β, µg/L | ||||
| Before treatment | 18.98±2.39 | 19.08±2.41 | −0.238 | 0.812 |
| After treatment | 4.03±0.38 | 8.38±0.42 | −61.92 | <0.001* |
*Difference is statistically significant at p<0.05.
NSE, neuron-specific enolase; S100β, astrocyte-derived protein.